Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY) Short Interest Down 50.0% in March

Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY) saw a large decrease in short interest in the month of March. As of March 31st, there was short interest totalling 100 shares, a decrease of 50.0% from the March 15th total of 200 shares. Based on an average daily volume of 1,800 shares, the days-to-cover ratio is currently 0.1 days.

Hikma Pharmaceuticals Stock Performance

Shares of HKMPY traded up $1.65 during midday trading on Thursday, hitting $50.35. The company had a trading volume of 448 shares, compared to its average volume of 996. Hikma Pharmaceuticals has a 1 year low of $45.97 and a 1 year high of $59.26. The company’s 50-day simple moving average is $53.38 and its 200-day simple moving average is $51.46.

Hikma Pharmaceuticals Increases Dividend

The company also recently declared a dividend, which will be paid on Monday, May 12th. Investors of record on Friday, March 21st will be paid a $0.94 dividend. The ex-dividend date is Friday, March 21st. This is an increase from Hikma Pharmaceuticals’s previous dividend of $0.62. Hikma Pharmaceuticals’s payout ratio is currently 10.34%.

Hikma Pharmaceuticals Company Profile

Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals.